Datroway Approved: New Targeted Therapy Offers Hope for Metastatic Breast Cancer
A new therapeutic horizon has arrived for patients battling metastatic breast cancer that has progressed despite hormone and chemotherapy.
Search results for "k-bio"
Daewoong Pharmaceutical’s ‘Ursa’ Shows Symptom Improvement in Early Post-COVID Patients
Daewoong Pharmaceutical announced on the 9th that Ursodeoxycholic Acid , the primary ingredient in its flagship product Ursa, has shown signs of...
Korean Biotech Firms Join Forces to Uncover the Hidden Profiles of Cancer Cells
Even within a single tumor, cancer cells present many different "faces." While they may appear as a uniform mass, every...
The 'Forever Chemical' in Your Frying Pan: Is It Accelerating Aging in Men?
Research has revealed that a modern component of the so-called "forever chemicals" , widely used in everyday household...
Rznomics to Present Oral Report on Breakthrough Anti-Cancer Gene Therapy at AACR
Rznomics, a biotechnology company specializing in RNA-based gene therapies, announced on March 5 that it has been...
Alteogen Poised for Surge in Milestone Revenue as Keytruda Qlex and Biosimilars Gain Momentum
Alteogen is set to accelerate its financial growth this year, driven by a surge in milestone payments and royalty...
FDA Approves Clinical Trial for Abl Bio’s Dual-Antibody ADC Candidate
Abl Bio announced on March 3rd that the U.S. Food and Drug Administration has approved the Investigational New Drug...
SK Bioscience Secures First EU-Led Vaccine Project in Landmark Triple Consortium
SK Bioscience announced on February 26th that a tripartite consortium including the company has been selected for the...
Is Your 'Focus Supplement' a Warning Sign? High Tyrosine Levels Linked to Shorter Lifespan in Men
Tyrosine, an amino acid widely marketed as a cognitive enhancer to sharpen focus, may be linked to a significant...
Hanmi’s 'Amoprel' Makes Global Waves: World’s First Ultra-Low Triple Hypertension Drug Lands in JACC
The Phase 3 clinical trial results for Hanmi Pharmaceutical’s Amoprel—the world’s first ultra-low-dose triple...